NEUTROPHIL PERCENTAGE DECREASED side effect
What is NEUTROPHIL PERCENTAGE DECREASED ?Drugs associated with NEUTROPHIL PERCENTAGE DECREASED
BEVACIZUMAB BISOPROLOL NEORAL PRAVASTATIN TYSABRINEUTROPHIL PERCENTAGE DECREASED : Neoral Side Effects Report #5532734-X
Physician from JAPAN reported NEORAL problem on Nov 26, 2007. Female patient, weighting 11.02 lb, was diagnosed with liver transplant, pyrexia, oedema, thrombosis prophylaxis, hypokalaemia and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: eosinophilia, neutrophil percentage decreased, platelet count decreased, white blood cell count increased, . NEORAL dosage: unknown. During the same period patient was treated with PROGRAF, SANDIMMUNE, PREDONINE, PREDNISOLONE ACETATE, SULPERAZON, LASIX, WARFARIN, KAYTWO. Patient was hospitalized. Patient recovered.
NEUTROPHIL PERCENTAGE DECREASED : Neoral Side Effects Report #5567823-7
NEORAL problem was reported by a Physician from JAPAN on Dec 14, 2007. Female patient, weighting 11.02 lb, was diagnosed with liver transplant, pyrexia, oedema, thrombosis prophylaxis, hypokalaemia and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: eosinophilia, neutrophil percentage decreased, platelet count decreased, white blood cell count increased, . NEORAL dosage: unknown. During the same period patient was treated with PROGRAF, SANDIMMUNE, PREDONINE, PREDNISOLONE ACETATE, SULPERAZON, LASIX, WARFARIN, KAYTWO. Patient was hospitalized. Patient recovered.
NEUTROPHIL PERCENTAGE DECREASED : Bevacizumab Side Effects Report #5483069-5
Consumer or non-health professional from UNITED KINGDOM reported BEVACIZUMAB problem on Sept 27, 2007. Female patient, weighting 92.37 lb, was diagnosed with non-small cell lung cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: c-reactive protein increased, neutrophil percentage decreased, pyrexia, white blood cell count decreased, . BEVACIZUMAB dosage: 629 MG, Q3W. During the same period patient was treated with PACLITAXEL, CARBOPLATIN, OXYCODONE, FENTANYL, METOCLOPRAMIDE, TRIAMCINOLONE, PROCHLORPERAZINE, LOXOPROFEN. Patient was hospitalized. Patient recovered.
NEUTROPHIL PERCENTAGE DECREASED : Bisoprolol Side Effects Report #5652210-3
BISOPROLOL FUMARATE problem was reported by a Consumer or non-health professional from JAPAN on Feb 29, 2008. Female patient, 81 years of age, was diagnosed with ventricular fibrillation and was treated with BISOPROLOL FUMARATE. After drug was administered, patient experienced the following problems/side effects: agranulocytosis, aptyalism, neutrophil percentage decreased, oral candidiasis, pyrexia, white blood cell count decreased, . BISOPROLOL FUMARATE dosage: unknown. During the same period patient was treated with BISOPROLOL FUMARATE, ASPENON, WARFARIN, ARICEPT, FLUCONAZOLE. Patient was hospitalized. Patient recovered.
NEUTROPHIL PERCENTAGE DECREASED : Pravastatin Side Effects Report #5660423-X
Consumer or non-health professional from GREECE reported PRAVASTATIN problem on Feb 25, 2008. Male patient, 60 years of age, was diagnosed with hypercholesterolaemia and was treated with PRAVASTATIN. After drug was administered, patient experienced the following problems/side effects: blood lactate dehydrogenase increased, lymphocyte percentage increased, neutrophil percentage decreased, pleural effusion, . PRAVASTATIN dosage: 40 MG; QD, 40 MG; QD. Patient recovered.
NEUTROPHIL PERCENTAGE DECREASED : Tysabri Side Effects Report #5683489-X
TYSABRI problem was reported by a Physician from UNITED STATES on Mar 12, 2008. Male patient, 54 years of age, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, mean cell haemoglobin concentration increased, neutrophil percentage decreased, platelet count decreased, white blood cell count increased, . TYSABRI dosage: 300 MG; QM; IV. Patient recovered.